Followers | 505 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
![](https://investorshub.advfn.com/uicon/475374.png?cb=1683825270)
Saturday, January 03, 2015 4:00:43 PM
bullish
$CDXS recent news/filings
## source: finance.yahoo.com
Wed, 03 Dec 2014 23:55:53 GMT ~ Codexis Uses Its CodeEvolver(R) Protein Engineering Platform Technology to Develop an Enzyme Therapeutic Candidate for the Potential Treatment of Phenylketonuria (PKU) via Oral Administration
[at noodls] - REDWOOD CITY, Calif., Dec. 3, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it has ...
read full: http://www.noodls.com/view/BCB45A980239118C760CAE73EFF4A285AAF49112
*********************************************************
Wed, 03 Dec 2014 23:38:20 GMT ~ Codexis Uses Its CodeEvolver(R) Protein Engineering Platform Technology to Develop an Enzyme Therapeutic Candidate for the Potential Treatment of Phenylketonuria (PKU) via Oral Administration
[GlobeNewswire] - REDWOOD CITY, Calif. -- Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it has developed a novel enzyme therapeutic product ...
read full: http://finance.yahoo.com/news/codexis-uses-codeevolver-r-protein-233820703.html
*********************************************************
Tue, 25 Nov 2014 13:31:11 GMT ~ Codexis to Present at the LD Micro Main Event VII Conference on December 4
[at noodls] - REDWOOD CITY, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will provide ...
read full: http://www.noodls.com/view/30B4493C1D2BE9EB9D0610A8436632F42BCCEA13
*********************************************************
Tue, 25 Nov 2014 13:00:00 GMT ~ Codexis to Present at the LD Micro Main Event VII Conference on December 4
[GlobeNewswire] - REDWOOD CITY, Calif. -- Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will provide a corporate update at the LD Micro Main ...
read full: http://finance.yahoo.com/news/codexis-present-ld-micro-main-130000448.html
*********************************************************
Fri, 21 Nov 2014 19:45:00 GMT ~ Insider Trading Alert - ITG, CDXS And ARQL Traded By Insiders
read full: http://www.thestreet.com/story/12963765/1/insider-trading-alert--itg-cdxs-and-arql-traded-by-insiders.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
$CDXS charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CDXS company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CDXS/company-info
Ticker: $CDXS
OTC Market Place: Not Available
CIK code: not found
Company name: Codexis, Inc.
Incorporated In:
Business Description:
$CDXS share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$CDXS extra dd links
Company name: Codexis, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CDXS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CDXS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CDXS+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CDXS/news - http://finance.yahoo.com/q/h?s=CDXS+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CDXS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CDXS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CDXS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CDXS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Codexis%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Codexis%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Codexis%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CDXS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CDXS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CDXS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CDXS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CDXS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CDXS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CDXS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CDXS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CDXS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CDXS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CDXS+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CDXS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CDXS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CDXS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CDXS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CDXS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CDXS/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CDXS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CDXS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CDXS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CDXS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CDXS
$CDXS DD Notes ~ http://www.ddnotesmaker.com/CDXS
Recent CDXS News
- Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets • GlobeNewswire Inc. • 07/01/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 10:28:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 10:28:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 10:27:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 10:27:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 10:27:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 10:26:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 10:25:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:04:54 PM
- Codexis to Participate in Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/22/2024 08:25:41 PM
- Codexis to Participate in TD Cowen 2nd Annual Sustainability Week • GlobeNewswire Inc. • 05/20/2024 08:05:14 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/14/2024 01:11:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 10:52:02 AM
- Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting • GlobeNewswire Inc. • 05/14/2024 10:00:00 AM
- Codexis Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- Codexis to Report First Quarter 2024 Financial Results on May 2 • GlobeNewswire Inc. • 04/18/2024 08:05:10 PM
- Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board • GlobeNewswire Inc. • 04/11/2024 11:05:13 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:02:33 PM
- Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 02/28/2024 09:05:00 PM
- Biotech Rallied Strongly On Exclusive Licensing Agreement • AllPennyStocks.com • 02/27/2024 05:15:00 PM
- Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche • GlobeNewswire Inc. • 02/26/2024 09:05:42 PM
- Codexis to Participate in TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/26/2024 01:05:47 PM
- Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board • GlobeNewswire Inc. • 02/20/2024 01:05:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:01:01 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:51:41 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM